Cargando…
Factors associated with pharmacological treatment in children with attention-deficit/hyperactivity disorders: a retrospective study of a series of 77 cases in a single third-level reference Centre in Apulia region
BACKGROUND: The present study analysed data on children and adolescents with a diagnosis of attention-deficit/hyperactivity disorder (ADHD) who were referred to the ADHD reference centre of Scientific Institute IRCCS E. Medea (Brindisi, Italy) for ADHD pharmacotherapy initiation and monitoring overt...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644404/ https://www.ncbi.nlm.nih.gov/pubmed/37957732 http://dx.doi.org/10.1186/s13052-023-01560-2 |
_version_ | 1785147222561652736 |
---|---|
author | Amendola, Simone Fanizza, Isabella Scoditti, Sara De Rinaldis, Marta Trabacca, Antonio |
author_facet | Amendola, Simone Fanizza, Isabella Scoditti, Sara De Rinaldis, Marta Trabacca, Antonio |
author_sort | Amendola, Simone |
collection | PubMed |
description | BACKGROUND: The present study analysed data on children and adolescents with a diagnosis of attention-deficit/hyperactivity disorder (ADHD) who were referred to the ADHD reference centre of Scientific Institute IRCCS E. Medea (Brindisi, Italy) for ADHD pharmacotherapy initiation and monitoring overtime. The main aim of the study was to examine differences in pharmacological treatment status (i.e., treatment continuation vs discontinuation) between patients. METHODS: Seventy-seven children and adolescents (mean age at pharmacotherapy initiation = 9.5, standard deviation = 2.6) with ADHD received drugs treatment for ADHD at the reference center between January, 2013 and May, 2022. Demographic and clinical data were obtained from the Italian Registry for ADHD and medical records. Child Behavior Checklist (CBCL) available data were used. RESULTS: Pharmacological treatment status was examined for patients (n = 63) with at least 12 months of follow-up after the first pharmacological treatment for ADHD. After starting pharmacotherapy treatment, 77.8% (n = 49) patients were still on treatment whereas 22.2% (n = 14) discontinued it. No between group difference were observed in demographic and clinical data except for the intelligence quotient/intellectual disability and rule-breaking behavior (n = 40). CONCLUSIONS: This study stressed the need of periodical assessments, monitoring difficulties with treatment and/or reasons for poor treatment compliance to provide individualized care. |
format | Online Article Text |
id | pubmed-10644404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106444042023-11-14 Factors associated with pharmacological treatment in children with attention-deficit/hyperactivity disorders: a retrospective study of a series of 77 cases in a single third-level reference Centre in Apulia region Amendola, Simone Fanizza, Isabella Scoditti, Sara De Rinaldis, Marta Trabacca, Antonio Ital J Pediatr Research BACKGROUND: The present study analysed data on children and adolescents with a diagnosis of attention-deficit/hyperactivity disorder (ADHD) who were referred to the ADHD reference centre of Scientific Institute IRCCS E. Medea (Brindisi, Italy) for ADHD pharmacotherapy initiation and monitoring overtime. The main aim of the study was to examine differences in pharmacological treatment status (i.e., treatment continuation vs discontinuation) between patients. METHODS: Seventy-seven children and adolescents (mean age at pharmacotherapy initiation = 9.5, standard deviation = 2.6) with ADHD received drugs treatment for ADHD at the reference center between January, 2013 and May, 2022. Demographic and clinical data were obtained from the Italian Registry for ADHD and medical records. Child Behavior Checklist (CBCL) available data were used. RESULTS: Pharmacological treatment status was examined for patients (n = 63) with at least 12 months of follow-up after the first pharmacological treatment for ADHD. After starting pharmacotherapy treatment, 77.8% (n = 49) patients were still on treatment whereas 22.2% (n = 14) discontinued it. No between group difference were observed in demographic and clinical data except for the intelligence quotient/intellectual disability and rule-breaking behavior (n = 40). CONCLUSIONS: This study stressed the need of periodical assessments, monitoring difficulties with treatment and/or reasons for poor treatment compliance to provide individualized care. BioMed Central 2023-11-14 /pmc/articles/PMC10644404/ /pubmed/37957732 http://dx.doi.org/10.1186/s13052-023-01560-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Amendola, Simone Fanizza, Isabella Scoditti, Sara De Rinaldis, Marta Trabacca, Antonio Factors associated with pharmacological treatment in children with attention-deficit/hyperactivity disorders: a retrospective study of a series of 77 cases in a single third-level reference Centre in Apulia region |
title | Factors associated with pharmacological treatment in children with attention-deficit/hyperactivity disorders: a retrospective study of a series of 77 cases in a single third-level reference Centre in Apulia region |
title_full | Factors associated with pharmacological treatment in children with attention-deficit/hyperactivity disorders: a retrospective study of a series of 77 cases in a single third-level reference Centre in Apulia region |
title_fullStr | Factors associated with pharmacological treatment in children with attention-deficit/hyperactivity disorders: a retrospective study of a series of 77 cases in a single third-level reference Centre in Apulia region |
title_full_unstemmed | Factors associated with pharmacological treatment in children with attention-deficit/hyperactivity disorders: a retrospective study of a series of 77 cases in a single third-level reference Centre in Apulia region |
title_short | Factors associated with pharmacological treatment in children with attention-deficit/hyperactivity disorders: a retrospective study of a series of 77 cases in a single third-level reference Centre in Apulia region |
title_sort | factors associated with pharmacological treatment in children with attention-deficit/hyperactivity disorders: a retrospective study of a series of 77 cases in a single third-level reference centre in apulia region |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10644404/ https://www.ncbi.nlm.nih.gov/pubmed/37957732 http://dx.doi.org/10.1186/s13052-023-01560-2 |
work_keys_str_mv | AT amendolasimone factorsassociatedwithpharmacologicaltreatmentinchildrenwithattentiondeficithyperactivitydisordersaretrospectivestudyofaseriesof77casesinasinglethirdlevelreferencecentreinapuliaregion AT fanizzaisabella factorsassociatedwithpharmacologicaltreatmentinchildrenwithattentiondeficithyperactivitydisordersaretrospectivestudyofaseriesof77casesinasinglethirdlevelreferencecentreinapuliaregion AT scodittisara factorsassociatedwithpharmacologicaltreatmentinchildrenwithattentiondeficithyperactivitydisordersaretrospectivestudyofaseriesof77casesinasinglethirdlevelreferencecentreinapuliaregion AT derinaldismarta factorsassociatedwithpharmacologicaltreatmentinchildrenwithattentiondeficithyperactivitydisordersaretrospectivestudyofaseriesof77casesinasinglethirdlevelreferencecentreinapuliaregion AT trabaccaantonio factorsassociatedwithpharmacologicaltreatmentinchildrenwithattentiondeficithyperactivitydisordersaretrospectivestudyofaseriesof77casesinasinglethirdlevelreferencecentreinapuliaregion |